Risk of malignancy in patients treated for systemic necrotising vasculitis.

Details

Request a copyRequest a copy
Serval ID
serval:BIB_6ABEE6226AA2
Type
Article: article from journal or magazin.
Publication sub-type
Letter (letter): Communication to the publisher.
Collection
Publications
Institution
UNIL/CHUV
Title
Risk of malignancy in patients treated for systemic necrotising vasculitis.
Journal
Annals of the rheumatic diseases
Author(s)
Lafarge A., Joseph A., Pagnoux C., Puechal X., Cohen P., Samson M., Hamidou M., Karras A., Groh M., Quemeneur T., Ribi C., Mouthon L., Guillevin L., Terrier B.
Working group(s)
French Vasculitis Study Group (FVSG)
ISSN
1468-2060 (Electronic)
ISSN-L
0003-4967
Publication state
Published
Issued date
03/2020
Peer-reviewed
Oui
Volume
79
Number
3
Pages
431-433
Language
english
Notes
Publication types: Evaluation Study ; Letter
Publication Status: ppublish
Keywords
Aged, Cyclophosphamide/administration & dosage, Female, Humans, Immunosuppressive Agents/administration & dosage, Male, Middle Aged, Necrosis, Neoplasms/etiology, Randomized Controlled Trials as Topic, Risk Factors, Treatment Outcome, Vasculitis/complications, Vasculitis/drug therapy, cancer, cyclophoshamide, immunosuppressive agents, rituximab, vasculitis
OAI-PMH
oai:serval.unil.ch:BIB_6ABEE6226AA2
DOI
10.1136/annrheumdis-2019-216452
Pubmed
31767700
Web of science
000519264600031
Create date
05/12/2019 23:38
Last modification date
03/07/2020 6:26
Usage data